Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Cefazolin with Daptomycin
Hospital Authority, Hong Kong
Periprosthetic Joint Infection
1 trial -
Chidamide
Hospital Authority, Hong Kong
AML
1 trial -
Clarithromycin
Chinese University of Hong Kong
Bronchiectasis Adult
1 trial -
Coffee
Hospital Authority, Hong Kong
Insulin Resistance
1 trial -
Combination group
Hospital Authority, Hong Kong
Cardiac Arrest
1 trial -
Computer Aided Diagnosis
Chinese University of Hong Kong
Upper Gastrointestinal Disorder
1 trial -
Crystalloid
Hospital Authority, Hong Kong
Acute Kidney Injury
1 trial -
Da Jian Zhong Tang (Zanthoxylum, Ginger, Ginseng, Maltose)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ERAS
1 trial -
Dapagliflozin
Hospital Authority, Hong Kong
Diabetes Mellitus, Type 2
1 trial -
Dexmedetomidine
Hospital Authority, Hong Kong
CABG
1 trial -
Diaphragmatic Ultrasound
Hospital Authority, Hong Kong
Diaphragmatic Paralysis
1 trial -
Du-Huo-Ji-Sheng-Tang (DHJST)
Chinese University of Hong Kong
Knee Osteoarthritis
1 trial -
EUS-guided portal vein and hepatic vein aspiration
Chinese University of Hong Kong
Circulating Tumor Cell
1 trial -
Eefooton oral solution
Hospital Authority, Hong Kong
Chronic Kidney Diseases
1 trial -
Elmental diet
Hospital Authority, Hong Kong
Gastro-oesophageal Reflux
1 trial -
Entecavir
Hospital Authority, Hong Kong
Hepatocellular Carcinoma
1 trial -
Exforge HCT® or Three Individual drug amlodipine + valsartan + hydrochlorothiazide
The University of Hong Kong
Intracerebral Hemorrhage
1 trial -
Ferrous Fumarate Oral Tablet
Hospital Authority, Hong Kong
Iron Deficiency Anemia Treatment
1 trial -
Fluorometholone
Hospital Authority, Hong Kong
Pterygium of the Conjunctiva and Cornea
1 trial -
Fluoxetine
The University of Hong Kong
Depression
1 trial -
Folic Acid
Hospital Authority, Hong Kong
Pregnant Women
1 trial -
Gabapentin
Hospital Authority, Hong Kong
Spinal Fusion
1 trial -
Glycerine Magnesium sulphate paste
Hospital Authority, Hong Kong
Infection
1 trial -
Group S: sugammadex injection
Hospital Authority, Hong Kong
Head and Neck Surgery
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources